Trabecular Titanium News Today

Three spine and orthopedic medtech companies provided updates related to acquisitions during the first quarter of 2024.

WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV, "Enovis" or the "Company")) an innovation-driven, medical technology growth company, today announced that it closed the

The Global Joint Reconstruction Devices Industry, currently valued at US$ 26 billion, is poised for remarkable growth, with projections indicating a surge to US$ 41.5 billion by the year 2032. This substantial expansion is expected to be driven by a steady Compound Annual Growth Rate (CAGR) of 4.8% throughout the pe...

Enovis, a medical technology growth company, has announced a definitive agreement to acquire LimaCorporate, a privately held global orthopaedic company focused on restoring motion through an innovative portfolio of implant solutions. The acquisition has an enterprise value of approximately €800 million, consisting of a €700 million cash payment at closing and €100 million in shares of Enovis common stock. Founded in 1945, Lima is an orthopedic company with diversified revenues that has gro...

Global sales of the Joint Replacement Market in 2021 will be valued at US$ 17.1 billion, according to Future Market Insights Joint Replacement Market analysis report. The market is expected to be worth US$ 27 billion by 2032, with a 4.3% CAGR from 2022 to 2032. From 2022 to 2032, knee replacement is expected to be t...

/PRNewswire/ -- EQT Private Equity announces the sale of LimaCorporate to Enovis. With this transaction, LimaCorporate will become part of the NYSE-listed...

Creating a high-growth, global reconstruction leader with ~$1 billion in annual revenueAttractive margin profile and meaningful synergies expected to increase profitability Wilmington, DE,...

EQT is pleased to announce that the EQT VII fund ("EQT Private Equity" or "EQT"), together with its...

Enovis Corp (NYSE: ENOV) inked a deal to acquire LimaCorporate S.p.A. for an

The global joint reconstruction devices market is worth US$ 26 Bn as of now and is expected to reach US$ 41.5 Bn by the year 2032 at a CAGR of 4.8% between 2022 and 2032.Joint reconstruction comes across as a remarkable part of global orthopedic devices vertical. The conditions adversely affecting joints are inclusi...